• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
UT Shield
Mulva Clinic for the Neurosciences
  • About
    • Leadership
    • Departments
      • Neurology
        • 5th Anniversary Report
      • Neurosurgery
      • Psychiatry & Behavioral Sciences
        • Annual Report
  • Research Areas
    • Aging & Neurodegenerative Diseases
    • Neuroinflamation & Neuroimmunology
    • Brain & Nervous System Injury
    • Development & Neuroplasticity
    • Addiction
    • Neurosurgery
    • PTSD
    • Mood Disorders
    • Neural Engineering & Data Sciences
  • Research Labs & Centers
  • Clinical Trials
  • Clinical Services
    • UT Health Austin Adult
    • UT Health Austin Pediatric Neurosciences
    • UT Health Austin Pediatric Psychiatry
  • News

Research Focus

October 13, 2022, Filed Under: News

Register: The Oskar Fisher Lecture Series: Neural Basis of a Silent Alzheimer’s Disease Phase

Oskar Fisher Lecture Series

Thursday, December 1, 2022
9-11 a.m. (CDT)
James J. & Miriam B. Mulva Auditorium
2501 Speedway
Austin, TX 78712
Networking reception with Dr. Slutsky and lecture discussants will follow the in-person event from 10-11am (CST).

The Oskar Fischer Lecture Series features invited scholars working at the vanguard of new ideas on the mechanisms, diagnosis and treatment of dementing illnesses.

The eighth lecture of the series will feature neuroscientist Inna Slutsky, Ph.D. Dr. Slutsky is the chair of the Department of Physiology and Pharmacology at the Sackler Faculty of Medicine, Tel Aviv University, Israel. Her research focuses on understanding the basic mechanisms that maintain stability-plasticity balance in hippocampal circuits and initiate circuit-wide dysfunctions during the presymptomatic phase of Alzheimer’s disease.

Using advanced optical imaging, electrophysiology and molecular biology tools, Dr. Slutsky’s team uncovered the mechanisms that drive synaptic, network and cognitive impairments in Alzheimer’s disease models. Currently, her team explores the principles and mechanisms underlying stability of neural circuits’ functioning and the role of mitochondria in this regulation. Recently, she proposed a new hypothesis stating that dysregulation of homeostatic firing rate set points during low-arousal brain states drives Alzheimer’s pathophysiology. Her recent discoveries form the basis of FutuRx’s company Selene Therapeutics, pioneering a new conceptual strategy to treat epilepsy and Alzheimer’s disease by lowering activity set points in brain circuits.

Professor Slutsky completed her Ph.D. at the Hebrew University of Jerusalem and postdoctoral study at the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology.

Learn more and register

This event has in-person and remote options for you to select from. Registration is required to receive the stream link

Primary Sidebar

Latest News

  • Five Faculty Members Promoted May 29, 2026
  • Register Now: Third Annual IMPRES Pediatric Research in Epilepsy Surgery Conference May 20, 2026
  • Fonzo and Melamed Promoted to Associate Professor April 19, 2026
  • Fonzo Team Recognized as Leading Research Achievement by the Brain and Behavior Research Foundation March 24, 2026
  • $1.45 Million Dementia Initiative Receives Continued Funding March 16, 2026
  • Howard & Brumback Study How Brain Circuit Processing Is Altered in Neurodevelopmental Disorders February 23, 2026

Footer

Contact us

UT Home | Emergency Information | Site Policies | Web Accessibility | Web Privacy | Adobe Reader

© The University of Texas at Austin 2026